$62.37
2.674.47%
At Close: -
$62.19
-0.18-0.29%
After Hours: 7:50 PM EDT
15 minutes delayed
Comments
Loading...
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Edwards Lifesciences (NYSE:EW) Stock, Analyst Ratings, Price Targets, Forecasts
Edwards Lifesciences Corp has a consensus price target of $83.67 based on the ratings of 26 analysts. The high is $107 issued by Jefferies on July 25, 2023. The low is $57 issued by Wolfe Research on November 28, 2023. The 3 most-recent analyst ratings were released by Barclays, Goldman Sachs, and TD Cowen on July 26, 2024, July 26, 2024, and July 25, 2024, respectively. With an average price target of $83.67 between Barclays, Goldman Sachs, and TD Cowen, there's an implied 34.53% upside for Edwards Lifesciences Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Barclays
Goldman Sachs
TD Cowen
Wells Fargo
Evercore ISI Group
1calculated from analyst ratings
Analyst Ratings for Edwards Lifesciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/26/2024 | Buy Now | 44.72% | Barclays | Matt Miksic | $101 → $90 | Maintains | Overweight | Get Alert |
| 07/26/2024 | Buy Now | 46.33% | Goldman Sachs | David Roman | $107 → $91 | Maintains | Buy | Get Alert |
| 07/25/2024 | Buy Now | 12.56% | TD Cowen | Joshua Jennings | $100 → $70 | Downgrade | Buy → Hold | Get Alert |
| 07/25/2024 | Buy Now | 44.72% | Wells Fargo | Larry Biegelsen | $99 → $90 | Maintains | Overweight | Get Alert |
| 07/25/2024 | Buy Now | 22.21% | Evercore ISI Group | Vijay Kumar | $91 → $76 | Maintains | In-Line | Get Alert |
| 07/25/2024 | Buy Now | 36.68% | Deutsche Bank | Pito Chickering | $103 → $85 | Maintains | Buy | Get Alert |
| 07/25/2024 | Buy Now | 36.68% | RBC Capital | Shagun Singh | $101 → $85 | Maintains | Outperform | Get Alert |
| 07/25/2024 | Buy Now | 31.85% | Truist Securities | Richard Newitter | $110 → $82 | Downgrade | Buy → Hold | Get Alert |
| 07/25/2024 | Buy Now | 12.56% | Stifel | Rick Wise | $85 → $70 | Maintains | Hold | Get Alert |
| 07/25/2024 | Buy Now | 44.72% | Oppenheimer | Suraj Kalia | $100 → $90 | Maintains | Outperform | Get Alert |
| 07/25/2024 | Buy Now | 23.81% | Canaccord Genuity | William Plovanic | $85 → $77 | Maintains | Hold | Get Alert |
| 07/25/2024 | Buy Now | 17.38% | Piper Sandler | Adam Maeder | $88 → $73 | Maintains | Neutral | Get Alert |
| 07/25/2024 | Buy Now | 20.6% | B of A Securities | Travis Steed | $105 → $75 | Downgrade | Buy → Neutral | Get Alert |
| 07/25/2024 | Buy Now | 15.77% | JP Morgan | Robbie Marcus | $105 → $72 | Downgrade | Overweight → Neutral | Get Alert |
| 07/25/2024 | Buy Now | 12.56% | Baird | David Rescott | $102 → $70 | Downgrade | Outperform → Neutral | Get Alert |
| 07/16/2024 | Buy Now | 76.88% | Truist Securities | Richard Newitter | $105 → $110 | Maintains | Buy | Get Alert |
| 07/10/2024 | Buy Now | 70.45% | Citigroup | Joanne Wuensch | $105 → $106 | Maintains | Buy | Get Alert |
| 07/02/2024 | Buy Now | 46.33% | Evercore ISI Group | Vijay Kumar | $89 → $91 | Maintains | In-Line | Get Alert |
| 05/30/2024 | Buy Now | 72.05% | Goldman Sachs | David Roman | → $107 | Initiates | → Buy | Get Alert |
| 05/22/2024 | Buy Now | 68.84% | Citigroup | Joanne Wuensch | $98 → $105 | Upgrade | Neutral → Buy | Get Alert |
| 05/14/2024 | Buy Now | 65.62% | Deutsche Bank | Pito Chickering | $86 → $103 | Upgrade | Hold → Buy | Get Alert |
| 05/07/2024 | Buy Now | 62.41% | Barclays | Matt Miksic | $100 → $101 | Maintains | Overweight | Get Alert |
| 04/26/2024 | Buy Now | 36.68% | Canaccord Genuity | William Plovanic | $86 → $85 | Maintains | Hold | Get Alert |
| 04/26/2024 | Buy Now | 59.19% | Wells Fargo | Larry Biegelsen | $94 → $99 | Maintains | Overweight | Get Alert |
| 04/26/2024 | Buy Now | 43.11% | Evercore ISI Group | Vijay Kumar | $92 → $89 | Maintains | In-Line | Get Alert |
| 04/26/2024 | Buy Now | 36.68% | Stifel | Rick Wise | $83 → $85 | Maintains | Hold | Get Alert |
| 04/26/2024 | Buy Now | 41.5% | Piper Sandler | Adam Maeder | $85 → $88 | Maintains | Neutral | Get Alert |
| 04/15/2024 | Buy Now | 62.41% | RBC Capital | Shagun Singh | $95 → $101 | Maintains | Outperform | Get Alert |
| 04/11/2024 | Buy Now | 68.84% | Mizuho | Anthony Petrone | $95 → $105 | Maintains | Buy | Get Alert |
| 04/04/2024 | Buy Now | 47.93% | Evercore ISI Group | Vijay Kumar | $86 → $92 | Maintains | In-Line | Get Alert |
| 04/03/2024 | Buy Now | 57.58% | Citigroup | Joanne Wuensch | $90 → $98 | Maintains | Neutral | Get Alert |
| 03/26/2024 | Buy Now | — | OTR Global | — | — | Upgrade | Mixed → Positive | Get Alert |
| 03/21/2024 | Buy Now | 65.62% | Morgan Stanley | Patrick Wood | $95 → $103 | Maintains | Overweight | Get Alert |
| 03/18/2024 | Buy Now | 60.8% | Oppenheimer | Suraj Kalia | $93 → $100 | Maintains | Outperform | Get Alert |
| 03/07/2024 | Buy Now | — | B of A Securities | Travis Steed | — | Upgrade | Neutral → Buy | Get Alert |
| 02/07/2024 | Buy Now | 33.46% | Stifel | Rick Wise | $70 → $83 | Maintains | Hold | Get Alert |
| 02/07/2024 | Buy Now | 52.76% | Morgan Stanley | Patrick Wood | $80 → $95 | Maintains | Overweight | Get Alert |
| 02/07/2024 | Buy Now | 52.76% | RBC Capital | Shagun Singh | $82 → $95 | Maintains | Outperform | Get Alert |
| 02/07/2024 | Buy Now | 52.76% | Mizuho | Anthony Petrone | $85 → $95 | Maintains | Buy | Get Alert |
| 02/02/2024 | Buy Now | 51.15% | Wells Fargo | Larry Biegelsen | → $94 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 01/12/2024 | Buy Now | 31.85% | RBC Capital | Shagun Singh | $80 → $82 | Maintains | Outperform | Get Alert |
| 01/04/2024 | Buy Now | 23.81% | Evercore ISI Group | Vijay Kumar | $80 → $77 | Downgrade | Outperform → In-Line | Get Alert |
| 12/22/2023 | Buy Now | 35.07% | Truist Securities | Richard Newitter | $78 → $84 | Maintains | Buy | Get Alert |
| 12/11/2023 | Buy Now | 25.42% | Truist Securities | Richard Newitter | $76 → $78 | Maintains | Buy | Get Alert |
| 12/11/2023 | Buy Now | — | Citigroup | Joanne Wuensch | — | Downgrade | Buy → Neutral | Get Alert |
| 12/04/2023 | Buy Now | 28.64% | Morgan Stanley | Patrick Wood | $102 → $80 | Maintains | Overweight | Get Alert |
| 11/28/2023 | Buy Now | -8.35% | Wolfe Research | Mike Polark | → $57 | Downgrade | Peer Perform → Underperform | Get Alert |
| 10/26/2023 | Buy Now | 12.56% | Stifel | Rick Wise | $87 → $70 | Maintains | Hold | Get Alert |
| 10/26/2023 | Buy Now | 36.68% | Mizuho | Anthony Petrone | $90 → $85 | Maintains | Buy | Get Alert |
| 10/26/2023 | Buy Now | 22.21% | Truist Securities | Richard Newitter | $83 → $76 | Maintains | Buy | Get Alert |
| 10/26/2023 | Buy Now | 31.85% | RBC Capital | Shagun Singh | $86 → $82 | Maintains | Outperform | Get Alert |
| 10/26/2023 | Buy Now | 9.34% | Piper Sandler | Adam Maeder | $83 → $68 | Maintains | Neutral | Get Alert |
| 10/26/2023 | Buy Now | 36.68% | Citigroup | Joanne Wuensch | $94 → $85 | Maintains | Buy | Get Alert |
| 10/26/2023 | Buy Now | 20.6% | Wells Fargo | Larry Biegelsen | $88 → $75 | Maintains | Equal-Weight | Get Alert |
| 10/16/2023 | Buy Now | 20.6% | Leerink Partners | Mike Kratky | → $75 | Initiates | → Market Perform | Get Alert |
| 10/02/2023 | Buy Now | 51.15% | Citigroup | Joanne Wuensch | $110 → $94 | Maintains | Buy | Get Alert |
| 09/26/2023 | Buy Now | 44.72% | Oppenheimer | Suraj Kalia | → $90 | Upgrade | Perform → Outperform | Get Alert |
| 09/08/2023 | Buy Now | 33.46% | Piper Sandler | Adam Maeder | $88 → $83 | Maintains | Neutral | Get Alert |
| 08/17/2023 | Buy Now | 54.37% | RBC Capital | Shagun Singh | → $96 | Reiterates | Outperform → Outperform | Get Alert |
| 08/01/2023 | Buy Now | 54.37% | RBC Capital | Shagun Singh | → $96 | Reiterates | Outperform → Outperform | Get Alert |
| 07/27/2023 | Buy Now | 64.01% | Morgan Stanley | Patrick Wood | $102 → $102 | Reiterates | Overweight → Overweight | Get Alert |
| 07/27/2023 | Buy Now | 54.37% | RBC Capital | Shagun Singh | → $96 | Reiterates | Outperform → Outperform | Get Alert |
| 07/27/2023 | Buy Now | 60.8% | JP Morgan | Robbie Marcus | $95 → $100 | Maintains | Overweight | Get Alert |
| 07/25/2023 | Buy Now | 72.05% | Jefferies | Matthew Taylor | $103 → $107 | Maintains | Buy | Get Alert |
| 07/19/2023 | Buy Now | 68.84% | Truist Securities | Richard Newitter | $101 → $105 | Maintains | Buy | Get Alert |
| 07/19/2023 | Buy Now | 72.05% | Baird | David Rescott | → $107 | Initiates | → Outperform | Get Alert |
| 07/14/2023 | Buy Now | 64.01% | Morgan Stanley | Patrick Wood | $102 → $102 | Reiterates | Overweight → Overweight | Get Alert |
| 07/11/2023 | Buy Now | 76.88% | Citigroup | Joanne Wuensch | $101 → $110 | Maintains | Buy | Get Alert |
| 06/27/2023 | Buy Now | 52.76% | Mizuho | Anthony Petrone | → $95 | Reiterates | Buy → Buy | Get Alert |
| 05/30/2023 | Buy Now | 64.01% | Morgan Stanley | Patrick Wood | → $102 | Assumes | → Overweight | Get Alert |
| 05/18/2023 | Buy Now | 62.41% | Truist Securities | Richard Newitter | $97 → $101 | Maintains | Buy | Get Alert |
| 05/04/2023 | Buy Now | 54.37% | RBC Capital | Shagun Singh | → $96 | Reiterates | → Outperform | Get Alert |
| 04/28/2023 | Buy Now | 64.01% | Barclays | Matt Miksic | $94 → $102 | Maintains | Overweight | Get Alert |
| 04/27/2023 | Buy Now | 62.41% | Citigroup | Joanne Wuensch | $97 → $101 | Maintains | Buy | Get Alert |
| 04/27/2023 | Buy Now | 55.97% | Truist Securities | Richard Newitter | $93 → $97 | Maintains | Buy | Get Alert |
| 04/27/2023 | Buy Now | 33.46% | Piper Sandler | Adam Maeder | $80 → $83 | Maintains | Neutral | Get Alert |
| 04/27/2023 | Buy Now | 54.37% | RBC Capital | Shagun Singh | $95 → $96 | Maintains | Outperform | Get Alert |
| 04/27/2023 | Buy Now | 64.01% | Morgan Stanley | Cecilia Furlong | $95 → $102 | Maintains | Overweight | Get Alert |
| 04/27/2023 | Buy Now | 44.72% | Wells Fargo | Larry Biegelsen | $78 → $90 | Maintains | Equal-Weight | Get Alert |
| 04/25/2023 | Buy Now | 52.76% | Mizuho | Anthony Petrone | $85 → $95 | Maintains | Buy | Get Alert |
| 04/24/2023 | Buy Now | 39.89% | Stifel | Rick Wise | $75 → $87 | Maintains | Hold | Get Alert |
| 04/17/2023 | Buy Now | 49.54% | Truist Securities | Richard Newitter | $86 → $93 | Maintains | Buy | Get Alert |
| 04/03/2023 | Buy Now | 55.97% | Citigroup | Joanne Wuensch | $92 → $97 | Maintains | Buy | Get Alert |
| 03/29/2023 | Buy Now | 35.07% | UBS | Danielle Antalffy | → $84 | Initiates | → Neutral | Get Alert |
| 03/08/2023 | Buy Now | 25.42% | Wells Fargo | Larry Biegelsen | $97 → $78 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 02/06/2023 | Buy Now | — | Raymond James | Jayson Bedford | — | Downgrade | Outperform → Market Perform | Get Alert |
| 02/01/2023 | Buy Now | 22.21% | Canaccord Genuity | William Plovanic | $68 → $76 | Maintains | Hold | Get Alert |
| 02/01/2023 | Buy Now | 38.29% | Truist Securities | Richard Newitter | $85 → $86 | Maintains | Buy | Get Alert |
| 01/30/2023 | Buy Now | 28.64% | Piper Sandler | Adam Maeder | $95 → $80 | Downgrade | Overweight → Neutral | Get Alert |
| 01/06/2023 | Buy Now | 52.76% | Morgan Stanley | Cecilia Furlong | $92 → $95 | Maintains | Overweight | Get Alert |
| 12/13/2022 | Buy Now | 33.46% | Raymond James | Jayson Bedford | $85 → $83 | Maintains | Outperform | Get Alert |
| 12/12/2022 | Buy Now | 47.93% | Citigroup | Joanne Wuensch | $99 → $92 | Maintains | Buy | Get Alert |
| 12/07/2022 | Buy Now | 36.68% | Mizuho | Anthony Petrone | $100 → $85 | Maintains | Buy | Get Alert |
| 12/06/2022 | Buy Now | 20.6% | Stifel | Rick Wise | $95 → $75 | Downgrade | Buy → Hold | Get Alert |
| 12/02/2022 | Buy Now | — | Wolfe Research | Mike Polark | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 11/28/2022 | Buy Now | 68.84% | RBC Capital | Shagun Singh | $118 → $105 | Maintains | Outperform | Get Alert |
| 11/03/2022 | Buy Now | 17.38% | Goldman Sachs | Amit Hazan | $97 → $73 | Maintains | Neutral | Get Alert |
| 10/31/2022 | Buy Now | 36.68% | Raymond James | Jayson Bedford | $120 → $85 | Maintains | Outperform | Get Alert |
| 10/28/2022 | Buy Now | 57.58% | Morgan Stanley | Cecilia Furlong | $108 → $98 | Maintains | Overweight | Get Alert |
| 10/28/2022 | Buy Now | 89.74% | RBC Capital | Shagun Singh | $128 → $118 | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Edwards Lifesciences (EW) stock?
The latest price target for Edwards Lifesciences (NYSE:EW) was reported by Barclays on July 26, 2024. The analyst firm set a price target for $90.00 expecting EW to rise to within 12 months (a possible 44.72% upside). 60 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Edwards Lifesciences (EW)?
The latest analyst rating for Edwards Lifesciences (NYSE:EW) was provided by Barclays, and Edwards Lifesciences maintained their overweight rating.
When was the last upgrade for Edwards Lifesciences (EW)?
The last upgrade for Edwards Lifesciences Corp happened on May 22, 2024 when Citigroup raised their price target to $105. Citigroup previously had a neutral for Edwards Lifesciences Corp.
When was the last downgrade for Edwards Lifesciences (EW)?
The last downgrade for Edwards Lifesciences Corp happened on July 25, 2024 when TD Cowen changed their price target from $100 to $70 for Edwards Lifesciences Corp.
When is the next analyst rating going to be posted or updated for Edwards Lifesciences (EW)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Edwards Lifesciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Edwards Lifesciences was filed on July 26, 2024 so you should expect the next rating to be made available sometime around July 26, 2025.
Is the Analyst Rating Edwards Lifesciences (EW) correct?
While ratings are subjective and will change, the latest Edwards Lifesciences (EW) rating was a maintained with a price target of $101.00 to $90.00. The current price Edwards Lifesciences (EW) is trading at is $62.19, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.